A Comprehensive Review of Recent Advancements in Cancer Immunotherapy and Generation of CAR T Cell by CRISPR-Cas9
出版年份 2021 全文链接
标题
A Comprehensive Review of Recent Advancements in Cancer Immunotherapy and Generation of CAR T Cell by CRISPR-Cas9
作者
关键词
-
出版物
Processes
Volume 10, Issue 1, Pages 16
出版商
MDPI AG
发表日期
2021-12-24
DOI
10.3390/pr10010016
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma
- (2021) Ken Ogasawara et al. CLINICAL PHARMACOKINETICS
- Intratumoral immunotherapy for early stage solid tumors
- (2020) Wan Xing Hong et al. CLINICAL CANCER RESEARCH
- Human T cells employ conserved AU‐rich elements to fine‐tune IFN‐γ production
- (2020) Julian J. Freen‐van Heeren et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road
- (2020) Michael D. Crowther et al. Cells
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
- (2020) Jeremy S Abramson et al. LANCET
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations
- (2019) Yongshuai Jiang et al. Human Vaccines & Immunotherapeutics
- ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression
- (2019) Yu Cao et al. Nature Communications
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer
- (2019) Steven Feins et al. AMERICAN JOURNAL OF HEMATOLOGY
- Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy
- (2019) Ang Gao et al. ACTA PHARMACOLOGICA SINICA
- Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
- (2019) Qianqian Gao et al. Cancer Medicine
- Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
- (2019) Weilei Hu et al. Frontiers in Immunology
- Adoptive cell therapy using engineered natural killer cells
- (2019) Katayoun Rezvani BONE MARROW TRANSPLANTATION
- Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy
- (2019) Donastas Sakellariou-Thompson et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Recent Advances in CAR-T Cell Therapy for Non-Hodgkin Lymphoma
- (2019) Avyakta Kallam et al. Clinical Lymphoma Myeloma & Leukemia
- Natural killer cell membrane infused biomimetic liposomes for targeted tumor therapy
- (2018) Arunkumar Pitchaimani et al. BIOMATERIALS
- The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy
- (2018) Hong-yan Wu et al. Briefings in Functional Genomics
- Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseases
- (2018) Umbreen Hafeez et al. CURRENT OPINION IN PHARMACOLOGY
- CAR T-cell Therapy: A New Era in Cancer Immunotherapy
- (2018) Miliotou N. Androulla et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- T cell exhaustion in cancer: Mechanisms and clinical implications
- (2018) Jin-Cheng Wang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Cancer immunotherapy beyond immune checkpoint inhibitors
- (2018) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside Efficacy
- (2018) Shivani Srivastava et al. JOURNAL OF IMMUNOLOGY
- Bispecific antibodies for cancer therapy: A review
- (2018) Anuradha Krishnamurthy et al. PHARMACOLOGY & THERAPEUTICS
- NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
- (2018) Remy Thomas et al. Frontiers in Immunology
- Redox control of cancer cell destruction
- (2018) Csaba Hegedűs et al. Redox Biology
- Interactions between Retroviruses and the Host Cell Genome
- (2018) Valentina Poletti et al. Molecular Therapy-Methods & Clinical Development
- Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population
- (2018) Vijaya L. Simhadri et al. Molecular Therapy-Methods & Clinical Development
- CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment
- (2018) Hasan Mollanoori et al. HUMAN IMMUNOLOGY
- Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics
- (2018) Karie Runcie et al. MOLECULAR MEDICINE
- Self-Supplied Tumor Oxygenation through Separated Liposomal Delivery of H2O2 and Catalase for Enhanced Radio-Immunotherapy of Cancer
- (2018) Xuejiao Song et al. NANO LETTERS
- Principles of adoptive T cell therapy in cancer
- (2018) Özcan Met et al. Seminars in Immunopathology
- Cytokine Release Syndrome with Chimeric Antigen Receptor T Cell Therapy
- (2018) Noelle Frey et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Cytokines in clinical cancer immunotherapy
- (2018) Pedro Berraondo et al. BRITISH JOURNAL OF CANCER
- CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
- (2018) Bagher Farhood et al. JOURNAL OF CELLULAR PHYSIOLOGY
- RNA-Based Immunostimulatory Liposomal Spherical Nucleic Acids as Potent TLR7/8 Modulators
- (2018) Chenxia Guan et al. Small
- Anti-CD19 Chimeric Antigen Receptor T Cell Therapies: Harnessing the Power of the Immune System to Fight Diffuse Large B Cell Lymphoma
- (2018) Robert Havard et al. Current Hematologic Malignancy Reports
- Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells
- (2017) Varun Sasidharan Nair et al. IMMUNOLOGY AND CELL BIOLOGY
- CAR T-cell therapy of solid tumors
- (2017) Carmen S M Yong et al. IMMUNOLOGY AND CELL BIOLOGY
- The Five Immune Forces Impacting DNA-Based Cancer Immunotherapeutic Strategy
- (2017) Suneetha Amara et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Engineering Natural Killer Cells for Cancer Immunotherapy
- (2017) Katayoun Rezvani et al. MOLECULAR THERAPY
- Immunotherapy: Tisagenlecleucel — the first approved CAR-T-cell therapy: implications for payers and policy makers
- (2017) Vinay Prasad Nature Reviews Clinical Oncology
- Cytokines in Cancer Immunotherapy
- (2017) Thomas A. Waldmann Cold Spring Harbor Perspectives in Biology
- A versatile system for rapid multiplex genome-edited CAR T cell generation
- (2017) Jiangtao Ren et al. Oncotarget
- T-cell receptor-engineered T cells for cancer treatment: current status and future directions
- (2017) Yu Ping et al. Protein & Cell
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Transcription Factor C/EBP Homologous Protein in Health and Diseases
- (2017) Yuan Yang et al. Frontiers in Immunology
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells-a completed study overview
- (2016) C. H. J. Lamers et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date
- (2016) Jae H. Park et al. BLOOD
- Prognostic value of tumor infiltrating lymphocyte subsets in breast cancer depends on hormone receptor status
- (2016) Yul Ri Chung et al. BREAST CANCER RESEARCH AND TREATMENT
- CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells
- (2016) Xiaojuan Liu et al. CELL RESEARCH
- Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
- (2016) Jiangtao Ren et al. CLINICAL CANCER RESEARCH
- CRISPR-Cas9: from Genome Editing to Cancer Research
- (2016) Si Chen et al. International Journal of Biological Sciences
- CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies
- (2016) Annette Romanski et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A CRISPR-Based Toolbox for Studying T Cell Signal Transduction
- (2016) Shen Chi et al. Biomed Research International
- Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer
- (2016) Laurence Buisseret et al. OncoImmunology
- Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma
- (2015) Zhenyu Xiao et al. CANCER LETTERS
- How Do Cytotoxic Lymphocytes Kill Cancer Cells?
- (2015) L. Martinez-Lostao et al. CLINICAL CANCER RESEARCH
- Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases
- (2015) S. C. Katz et al. CLINICAL CANCER RESEARCH
- Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9
- (2015) Chang Li et al. JOURNAL OF GENERAL VIROLOGY
- Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
- (2015) Kurt Schönfeld et al. MOLECULAR THERAPY
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
- (2015) Ayal Hendel et al. NATURE BIOTECHNOLOGY
- Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers
- (2015) Isaac B Hilton et al. NATURE BIOTECHNOLOGY
- Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes
- (2015) Ignazio Caruana et al. NATURE MEDICINE
- NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
- (2015) Aaron P Rapoport et al. NATURE MEDICINE
- Functional annotation of native enhancers with a Cas9–histone demethylase fusion
- (2015) Nicola A Kearns et al. NATURE METHODS
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
- (2015) Kathrin Schumann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Overcoming T cell exhaustion in infection and cancer
- (2015) Kristen E. Pauken et al. TRENDS IN IMMUNOLOGY
- T-cell exhaustion in the tumor microenvironment
- (2015) Y Jiang et al. Cell Death & Disease
- Tumor infiltrating lymphocyte therapy for ovarian cancer and renal cell carcinoma
- (2015) Rikke Andersen et al. Human Vaccines & Immunotherapeutics
- Characterization of thein vivoimmune network of IDO, tryptophan metabolism, PD-L1, andCTLA-4in circulating immune cells in melanoma
- (2015) I Chevolet et al. OncoImmunology
- Antibody-modified T cells: CARs take the front seat for hematologic malignancies
- (2014) M. V. Maus et al. BLOOD
- Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy
- (2014) Christian P. Pallasch et al. CELL
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma
- (2014) T. Chodon et al. CLINICAL CANCER RESEARCH
- A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
- (2014) P. F. Robbins et al. CLINICAL CANCER RESEARCH
- Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer
- (2014) V. Tiriveedhi et al. CLINICAL CANCER RESEARCH
- Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
- (2014) S. Kim et al. GENOME RESEARCH
- Engineering α-fetoprotein-based gene vaccines to prevent and treat hepatocellular carcinoma: review and future prospects
- (2014) Yukai He et al. Immunotherapy
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9
- (2014) Lukasz Swiech et al. NATURE BIOTECHNOLOGY
- Protease Inhibitors from Marine Actinobacteria as a Potential Source for Antimalarial Compound
- (2014) L. Karthik et al. PLoS One
- CCR5 Gene Disruption via Lentiviral Vectors Expressing Cas9 and Single Guided RNA Renders Cells Resistant to HIV-1 Infection
- (2014) Weiming Wang et al. PLoS One
- S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer
- (2014) S Dakhel et al. Oncogenesis
- Blinatumomab, a Bi-Specific Anti-CD19/CD3 BiTE® Antibody for the Treatment of Acute Lymphoblastic Leukemia: Perspectives and Current Pediatric Applications
- (2014) Lindsey M. Hoffman et al. Frontiers in Oncology
- Simultaneous Targeting of Tumor Antigens and the Tumor Vasculature Using T Lymphocyte Transfer Synergize to Induce Regression of Established Tumors in Mice
- (2013) D. Chinnasamy et al. CANCER RESEARCH
- Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system
- (2013) Albert W Cheng et al. CELL RESEARCH
- Cancer translocations in human cells induced by zinc finger and TALE nucleases
- (2013) M. Piganeau et al. GENOME RESEARCH
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Engineering T cells for cancer: our synthetic future
- (2013) Robert H. Vonderheide et al. IMMUNOLOGICAL REVIEWS
- CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
- (2013) J Chu et al. LEUKEMIA
- Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells
- (2013) Hua Jiang et al. Molecular Oncology
- Multiplex and homologous recombination–mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9
- (2013) Jian-Feng Li et al. NATURE BIOTECHNOLOGY
- Efficient genome editing in zebrafish using a CRISPR-Cas system
- (2013) Woong Y Hwang et al. NATURE BIOTECHNOLOGY
- Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems
- (2013) James E. DiCarlo et al. NUCLEIC ACIDS RESEARCH
- An Efficient Low Cost Method for Gene Transfer to T Lymphocytes
- (2013) Leonardo Chicaybam et al. PLoS One
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
- (2013) Zakaria Grada et al. Molecular Therapy-Nucleic Acids
- Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity
- (2013) Laurent Boissel et al. OncoImmunology
- The Effects of TLR Activation on T-Cell Development and Differentiation
- (2012) Bo Jin et al. Clinical & Developmental Immunology
- Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
- (2012) Richard A. Morgan et al. HUMAN GENE THERAPY
- Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling
- (2012) Scott Wilkie et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma
- (2012) Farhad Azimi et al. JOURNAL OF CLINICAL ONCOLOGY
- Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
- (2012) Elena Provasi et al. NATURE MEDICINE
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- How does the kinase Lck phosphorylate the T cell receptor? Spatial organization as a regulatory mechanism
- (2012) Jérémie Rossy et al. Frontiers in Immunology
- Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor
- (2011) E. K. Moon et al. CLINICAL CANCER RESEARCH
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- CARs on Track in the Clinic
- (2011) Donald B Kohn et al. MOLECULAR THERAPY
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III
- (2011) Elitza Deltcheva et al. NATURE
- T cell exhaustion
- (2011) E John Wherry NATURE IMMUNOLOGY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- On the Composition of the Preimmune Repertoire of T Cells Specific for Peptide–Major Histocompatibility Complex Ligands
- (2010) Marc K. Jenkins et al. Annual Review of Immunology
- Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
- (2010) J. N. Kochenderfer et al. BLOOD
- Vaccines and Immunotherapeutics for the Treatment of Malignant Disease
- (2010) Joel F. Aldrich et al. Clinical & Developmental Immunology
- Personalized cancer vaccines
- (2010) Kewal K Jain EXPERT OPINION ON BIOLOGICAL THERAPY
- PD1 as a common candidate susceptibility gene of subacute sclerosing panencephalitis
- (2010) Yoshito Ishizaki et al. HUMAN GENETICS
- NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
- (2010) Jeffrey E. Rubnitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of anti-CD3 and anti-CD28-coated beads with soluble anti-CD3 for expanding human T cells: Differing impact on CD8 T cell phenotype and responsiveness to restimulation
- (2010) Yixin Li et al. Journal of Translational Medicine
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- T Cell Activation
- (2009) Jennifer E. Smith-Garvin et al. Annual Review of Immunology
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- Nuclear signalling by tumour-associated antigen EpCAM
- (2009) Dorothea Maetzel et al. NATURE CELL BIOLOGY
- Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy
- (2008) J. Marlind et al. CLINICAL CANCER RESEARCH
- Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody
- (2008) R. Bargou et al. SCIENCE
- TCR Triggering by the pMHC Complex: Valency, Affinity, and Dynamics
- (2008) R. Varma Science Signaling
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation